These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2902095)

  • 1. The production and evaluation of monoclonal antibodies to Clostridium perfringens type D epsilon toxin.
    Boarer CD; Sojka MG; White VJ; Roeder PL
    J Biol Stand; 1988 Jul; 16(3):207-18. PubMed ID: 2902095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production and evaluation of a monoclonal antibody to Clostridium perfringens type D epsilon toxin.
    El-Enbaawy MI; Abdalla YA; Hussein AZ; Osman RM; Selim SA
    Egypt J Immunol; 2003; 10(1):77-81. PubMed ID: 15719625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of monoclonal antibodies suitable for use in antigen quantification potency tests for clostridial veterinary vaccines.
    Hauer PJ; Clough NE
    Dev Biol Stand; 1999; 101():85-94. PubMed ID: 10566780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Clostridium perfringens type D epsilon antitoxin in serum of goats by competitive and indirect ELISA.
    Uzal FA; Nielsen K; Kelly WR
    Vet Microbiol; 1997 Sep; 57(2-3):223-31. PubMed ID: 9355257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality assurance of C. perfringens epsilon toxoid vaccines--ELISA versus mouse neutralisation test.
    Rosskopf-Streicher U; Volkers P; Noeske K; Werner E
    ALTEX; 2004; 21 Suppl 3():65-9. PubMed ID: 15057410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional analysis of neutralizing antibodies against Clostridium perfringens epsilon-toxin.
    McClain MS; Cover TL
    Infect Immun; 2007 Apr; 75(4):1785-93. PubMed ID: 17261609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning of Clostridium perfringens epsilon-toxin gene and its high level expression in E. coli.
    Goswami PP; Rupa P; Prihar NS; Garg LC
    Biochem Biophys Res Commun; 1996 Sep; 226(3):735-40. PubMed ID: 8831683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Clostridium perfringens alpha toxin by enzyme-linked immunosorbent assay.
    Naylor RD; Martin PK; Barker LT
    Res Vet Sci; 1997; 63(1):101-2. PubMed ID: 9368967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naturally acquired antibodies against Clostridium perfringens epsilon toxin in goats.
    Veschi JL; Bruzzone OA; Losada-Eaton DM; Dutra IS; Fernandez-Miyakawa ME
    Vet Immunol Immunopathol; 2008 Sep; 125(1-2):198-202. PubMed ID: 18538416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies against alpha toxin of Clostridium perfringens.
    Sato H; Chiba J; Sato Y
    FEMS Microbiol Lett; 1989 May; 50(1-2):173-6. PubMed ID: 2544482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium perfringens alpha-toxin and NetB toxin antibodies and their possible role in protection against necrotic enteritis and gangrenous dermatitis in broiler chickens.
    Lee KW; Lillehoj HS; Park MS; Jang SI; Ritter GD; Hong YH; Jeong W; Jeoung HY; An DJ; Lillehoj EP
    Avian Dis; 2012 Mar; 56(1):230-3. PubMed ID: 22545552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of Clostridium perfringens vaccines using an indirect competitive ELISA for the epsilon toxin component - examination of the assay by a collaborative study.
    Rosskopf-Streicher U; Volkers P; Werner E
    Pharmeuropa Bio; 2004 Jan; 2003(2):91-6. PubMed ID: 14960265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lambda-toxin of Clostridium perfringens activates the precursor of epsilon-toxin by releasing its N- and C-terminal peptides.
    Minami J; Katayama S; Matsushita O; Matsushita C; Okabe A
    Microbiol Immunol; 1997; 41(7):527-35. PubMed ID: 9272698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and prevalidation of two different ELISA systems for the potency testing of Clostridium perfringens beta and epsilon-toxoid containing veterinary vaccines.
    Ebert E; Oppling V; Werner E; Cussler K
    FEMS Immunol Med Microbiol; 1999 Jul; 24(3):299-311. PubMed ID: 10397315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody response to the epsilon toxin of Clostridium perfringens following vaccination of Lama glama crias.
    Bentancor AB; Halperin P; Flores M; Iribarren F
    J Infect Dev Ctries; 2009 Sep; 3(8):624-7. PubMed ID: 19801806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epsilon-toxin is required for most Clostridium perfringens type D vegetative culture supernatants to cause lethality in the mouse intravenous injection model.
    Sayeed S; Fernandez-Miyakawa ME; Fisher DJ; Adams V; Poon R; Rood JI; Uzal FA; McClane BA
    Infect Immun; 2005 Nov; 73(11):7413-21. PubMed ID: 16239541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of Clostridium perfringens beta-toxin production by surface plasmon resonance immunoassay.
    Hsieh HV; Stewart B; Hauer P; Haaland P; Campbell R
    Vaccine; 1998; 16(9-10):997-1003. PubMed ID: 9682350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and evaluation of various enzyme-linked immunosorbent assays for the detection of Clostridium perfringens beta anti-toxins.
    Krt B
    FEMS Immunol Med Microbiol; 1999 Jul; 24(3):293-7. PubMed ID: 10397314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and characterization of antibodies to Clostridium perfringens epsilon toxin from hyperimmune horse serum.
    Worthington RW; Mülders MS
    Onderstepoort J Vet Res; 1979 Sep; 46(3):121-4. PubMed ID: 233148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of double sandwich ELISA for Clostridium perfringens beta and epsilon toxins.
    el Idrissi AH; Ward GE
    Vet Microbiol; 1992 Apr; 31(1):89-99. PubMed ID: 1615638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.